Literature DB >> 24318826

Protein/peptide transduction in metanephric explant culture.

Sergey Plisov1, Honghe Wang, Nadya Tarasova, Nirmala Sharma, Alan O Perantoni.   

Abstract

While gene targeting methods have largely supplanted cell/explant culture models for studying developmental processes, they have not eliminated the need for or value of such approaches in the investigator's technical arsenal. Explant culture models, such as those devised for the metanephric kidney and its progenitors, remain invaluable as tools for screening regulatory factors involved in tissue induction or in the inhibition of progenitor specification. Thus, some factors capable of inducing tissue condensations or nephronic tubule formation in explants of metanephric mesenchyme have been identified through direct treatment of cultures rather than lengthy genetic engineering in animals. Unfortunately, renal progenitors are largely refractory to most contemporary methods for gene manipulation, including transfection and viral transduction, so the applications of explant culture have been rather limited. However, methods for protein or peptide transduction offer greatly improved efficiencies for uptake and expression/regulation of proteins within cells and tissues. Biologically active TAT- or penetratin-fusion proteins/peptides are readily taken up by most cells in metanephric explants or monolayer cultured cells (Plisov et al., J Am Soc Nephrol 16:1632-1644, 2005; Osafune et al., Development 133:151-161, 2006; Wang et al., Cell Signal 22:1717-1726, 2010; Tanigawa, Dev Biol 352:58-69, 2011), allowing a direct functional evaluation of theoretically any protein, including biologically active enzymes and transcription factors, or any targeted interactive domain within a protein.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24318826      PMCID: PMC7670307          DOI: 10.1007/978-1-60327-292-6_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Cited1 is a bifunctional transcriptional cofactor that regulates early nephronic patterning.

Authors:  Sergey Plisov; Michael Tsang; Genbin Shi; Scott Boyle; Kiyoshi Yoshino; Sally L Dunwoodie; Igor B Dawid; Toshi Shioda; Alan O Perantoni; Mark P de Caestecker
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

2.  Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay.

Authors:  Kenji Osafune; Minoru Takasato; Andreas Kispert; Makoto Asashima; Ryuichi Nishinakamura
Journal:  Development       Date:  2005-11-30       Impact factor: 6.868

Review 3.  Utilizing peptide structures as keys for unlocking challenging targets.

Authors:  David Fry; Hongmao Sun
Journal:  Mini Rev Med Chem       Date:  2006-09       Impact factor: 3.862

Review 4.  Influence of protein transduction domains on intracellular delivery of macromolecules.

Authors:  Christopher L Murriel; Steven F Dowdy
Journal:  Expert Opin Drug Deliv       Date:  2006-11       Impact factor: 6.648

Review 5.  TAT transduction: the molecular mechanism and therapeutic prospects.

Authors:  Jacob M Gump; Steven F Dowdy
Journal:  Trends Mol Med       Date:  2007-10       Impact factor: 11.951

6.  STAT1 activation regulates proliferation and differentiation of renal progenitors.

Authors:  Honghe Wang; Yili Yang; Nirmala Sharma; Nadya I Tarasova; Olga A Timofeeva; Robin T Winkler-Pickett; Shunsuke Tanigawa; Alan O Perantoni
Journal:  Cell Signal       Date:  2010-07-17       Impact factor: 4.315

7.  Wnt4 induces nephronic tubules in metanephric mesenchyme by a non-canonical mechanism.

Authors:  Shunsuke Tanigawa; Honghe Wang; Yili Yang; Nirmala Sharma; Nadya Tarasova; Rieko Ajima; Terry P Yamaguchi; Luis G Rodriguez; Alan O Perantoni
Journal:  Dev Biol       Date:  2011-01-21       Impact factor: 3.582

8.  In vivo protein transduction: delivery of a biologically active protein into the mouse.

Authors:  S R Schwarze; A Ho; A Vocero-Akbani; S F Dowdy
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

9.  Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target.

Authors:  Olga A Timofeeva; Vadim Gaponenko; Stephen J Lockett; Sergey G Tarasov; Sheng Jiang; Christopher J Michejda; Alan O Perantoni; Nadya I Tarasova
Journal:  ACS Chem Biol       Date:  2007-12-21       Impact factor: 5.100

10.  Semaphorin3a inhibits ureteric bud branching morphogenesis.

Authors:  Alda Tufro; Jason Teichman; Craig Woda; Guillermo Villegas
Journal:  Mech Dev       Date:  2007-12-28       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.